Skip to content

Recovery Legal Care Randomized Trial

Health Impact of the "Recovery Legal Care" Medical-Legal Partnership

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07764458
Acronym
HVIP-MLP
Enrollment
200
Registered
2026-08-14
Start date
2026-05-11
Completion date
2027-07-31
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Economic Problems, Firearm Injury, Injury Traumatic

Brief summary

Hospital-Based Violence Intervention Programs (HVIPs) affiliated with U.S. trauma centers often focus on individual behavior modification to reduce re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing social and economic risks, often the root cause of violent injury and preventable homicide. This study tests a novel Medical-Legal Partnership that offers legal support to address social and economic risks, reduce perceived stress, and reduce firearm injury, while collaborating with the CFVP Coordinating Center for broad trauma center distribution and public health impact.

Detailed description

National trauma center verification relies on a commitment to injury prevention efforts, including prevention of community-level violence. Hospital-Based Violence Recovery Programs (HVIPs) have expanded across the country as extensions of Level I and II trauma centers to address trauma recidivism with individual behavioral modification during the "teachable moment". There is no evidence to date that has demonstrated effectiveness in this approach for HVIPs, despite proliferation across the country. A criticism of this approach to violence prevention is the difficulty for community-based violence prevention specialists from HVIP programs to address the broader social and economic risk factors that lead to violence through individual behavior modification. Medical-Legal Partnerships (MLPs) have been one approach that has demonstrated evidence and success in improving health outcomes and reducing health-harming legal needs of patients by connecting legal experts to medical experts for holistic care. The MLP approach has yet to be done for trauma patients and has not been incorporated into any HVIP approach thus far. In the study's biphasic proposal, the UG3 aims are to clearly identify the types of health-harming legal needs of patients and families affected by firearm violence and examine the population-level differences in types of legal needs by sociodemographic and geographic factors. The investigators then aim to develop the HVIP-MLP model for implementation at an urban, Level I Trauma Center on the South Side of Chicago. The UH3 aims are to examine implementation outcomes (acceptability and feasibility) of this novel MLP compared to standard of care with HVIP; and examine health outcomes via a clinical trial measuring primary health outcome (perceived stress) and secondary outcomes (improvements in legal need self-efficacy, PTSD symptoms, and firearm aggression and victimization). Close coordination with the CFVP Coordinating Center will be essential for data handling, measurement, analytics support and consultation with future public/stakeholder engagement and dissemination to demonstrate public health impact. This novel HVIP-MLP approach has the potential to broadly impact the HVIP model to include an MLP component to all trauma centers for verification to support patients, families and providers alike in this important public health work.

Interventions

These patients will receive support from our HVIP standard of care (Violence Recovery Program) plus our Medical Legal Partnership (Recovery Legal Care) for additional legal support to address health-harming legal needs and public benefits.

These patients will receive HVIP standard of care (Violence Recovery Program Support).

Sponsors

University of Chicago
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Treatment for an interpersonal violent injury at the University of Chicago Trauma Center (e.g., gunshot, stab wound, assault) * Ages 14+ years * Able to provide informed consent (18 years and older) or assent (14-17 years)

Exclusion criteria

* Unable to provide informed consent due to mental status or severe mental illness * Prior receipt of legal services at UCMC within the past year * Currently imprisoned or incarcerated * Residing at a non-Illinois address * Non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
Perceived StressBaseline, 3 months, 6 months, 12 monthsThe Perceived Stress Scale-10 (PSS-10) is a 10-item psychological questionnaire used to measure how unpredictable, uncontrollable, and overloaded a person feels over the last month. Scores range from 0 to 40, with higher numbers meaning higher stress.

Secondary

MeasureTime frameDescription
Firearm victimization and aggressionBaseline, 3 months, 6 months, 12 monthsThe adapted Conflict Tactics Scale 2 (CTS2) measures behaviors related to firearm victimization and aggression. The adapted version includes 3 items on non-partner victimization and 3 items on non-partner aggression, each rated on a 7-point frequency scale (never to 20+ times). Each domain generates a score from 0 to 18 with a higher score indicating higher victimization or aggression.
Legal needs self-efficacyBaseline, 3 months, 6 months, 12 monthsAdapted Bandura Self-Efficacy Scale measures belief in one's ability to have legal needs addressed and is scored on a scale from 0 to 100, with a higher score indicating higher self-efficacy.

Countries

United States

Contacts

CONTACTTanya L Zakrison, MD, MPH
tzakrison@bsd.uchicago.edu786-266-2228
CONTACTElizabeth L Tung, MD, MS
etung2@bsd.uchicago.edu773-702-6840

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026